Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers.

Dave Schmahl

(714) 620-9112

dschmahl@exelixis.com

www.Exelixis.com

Photo- Dave Schmahl.jpg

CONTACT